Global Opioid-Induced Constipation Competitive Landscape Professional Research Report 2025
Description
Global Opioid-Induced Constipation Competitive Landscape Professional Research Report 2025
Research Summary
Opioid-induced constipation (OIC) is a common and distressing side effect associated with the use of opioid medications for pain management. Opioids, which include prescription medications like morphine and oxycodone, as well as illicit drugs such as heroin, can slow down the digestive system and lead to infrequent, difficult, and painful bowel movements. OIC can cause significant discomfort, impact a person＇s quality of life, and, if left untreated, may result in serious complications such as bowel blockages. Healthcare providers often recommend various treatments, including lifestyle changes, dietary modifications, and specific medications, to alleviate OIC and improve the overall well-being of individuals on opioid therapy while ensuring effective pain management.
According to DIResearch's in-depth investigation and research, the global Opioid-Induced Constipation market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Opioid-Induced Constipation include Ironwood Pharmaceuticals, Daiichi Sankyo, Pfizer, Progenics Pharmaceuticals, Shionogi, Allergan, Nektar Therapeutics, Purdue Pharma, S.L.A. Pharma, Mundipharma International, Ono Pharmaceutical, Takeda Pharmaceutical Company, Theravance Biopharma, Bausch Health, Cosmo Pharmaceuticals, Daewoong Pharmaceutical, C.B. Fleet Company, Sucampo Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Opioid-Induced Constipation. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Opioid-Induced Constipation market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Opioid-Induced Constipation market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Opioid-Induced Constipation industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Opioid-Induced Constipation Include:
Ironwood Pharmaceuticals
Daiichi Sankyo
Pfizer
Progenics Pharmaceuticals
Shionogi
Allergan
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma
Mundipharma International
Ono Pharmaceutical
Takeda Pharmaceutical Company
Theravance Biopharma
Bausch Health
Cosmo Pharmaceuticals
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Opioid-Induced Constipation Product Segment Include:
Lubiprostone
Methylnaltrexone Bromide
Naldemedine
Alvimopan
Others
Opioid-Induced Constipation Product Application Include:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Opioid-Induced Constipation Industry PESTEL Analysis
Chapter 3: Global Opioid-Induced Constipation Industry Porter’s Five Forces Analysis
Chapter 4: Global Opioid-Induced Constipation Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Opioid-Induced Constipation Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Opioid-Induced Constipation Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Opioid-Induced Constipation Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Opioid-Induced Constipation Product by Type
- 1.2.1 Lubiprostone
- 1.2.2 Methylnaltrexone Bromide
- 1.2.3 Naldemedine
- 1.2.4 Alvimopan
- 1.2.5 Others
- 1.3 Opioid-Induced Constipation Product by Application
- 1.3.1 Hospital Pharmacy
- 1.3.2 Retail Pharmacy
- 1.3.3 Online Pharmacy
- 1.4 Global Opioid-Induced Constipation Market Revenue and Sales Analysis
- 1.4.1 Global Opioid-Induced Constipation Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Opioid-Induced Constipation Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Opioid-Induced Constipation Market Sales Price Trend Analysis (2020-2032)
- 1.5 Opioid-Induced Constipation Industry Trends and Innovation
- 1.5.1 Opioid-Induced Constipation Industry Trends and Innovation
- 1.5.2 Opioid-Induced Constipation Market Drivers and Challenges
- 2 Opioid-Induced Constipation Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Opioid-Induced Constipation Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Opioid-Induced Constipation Market Analysis by Regions
- 4.1 Opioid-Induced Constipation Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Opioid-Induced Constipation Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Opioid-Induced Constipation Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Opioid-Induced Constipation Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Opioid-Induced Constipation Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Opioid-Induced Constipation Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Opioid-Induced Constipation Sales Forecast by Region (2026-2032)
- 4.4 Global Opioid-Induced Constipation Sales Price Trend Analysis (2020-2032)
- 5 Global Opioid-Induced Constipation Market Size by Type and Application
- 5.1 Global Opioid-Induced Constipation Market Size by Type
- 5.1.1 Global Opioid-Induced Constipation Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Opioid-Induced Constipation Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Opioid-Induced Constipation Market Size by Application
- 5.2.1 Global Opioid-Induced Constipation Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Opioid-Induced Constipation Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Opioid-Induced Constipation Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Opioid-Induced Constipation Market Size by Type
- 6.3.1 North America Opioid-Induced Constipation Sales by Type (2020-2032)
- 6.3.2 North America Opioid-Induced Constipation Revenue by Type (2020-2032)
- 6.4 North America Opioid-Induced Constipation Market Size by Application
- 6.4.1 North America Opioid-Induced Constipation Sales by Application (2020-2032)
- 6.4.2 North America Opioid-Induced Constipation Revenue by Application (2020-2032)
- 6.5 North America Opioid-Induced Constipation Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Opioid-Induced Constipation Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Opioid-Induced Constipation Market Size by Type
- 7.3.1 Europe Opioid-Induced Constipation Sales by Type (2020-2032)
- 7.3.2 Europe Opioid-Induced Constipation Revenue by Type (2020-2032)
- 7.4 Europe Opioid-Induced Constipation Market Size by Application
- 7.4.1 Europe Opioid-Induced Constipation Sales by Application (2020-2032)
- 7.4.2 Europe Opioid-Induced Constipation Revenue by Application (2020-2032)
- 7.5 Europe Opioid-Induced Constipation Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Opioid-Induced Constipation Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Opioid-Induced Constipation Market Size by Type
- 8.3.1 China Opioid-Induced Constipation Sales by Type (2020-2032)
- 8.3.2 China Opioid-Induced Constipation Revenue by Type (2020-2032)
- 8.4 China Opioid-Induced Constipation Market Size by Application
- 8.4.1 China Opioid-Induced Constipation Sales by Application (2020-2032)
- 8.4.2 China Opioid-Induced Constipation Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Opioid-Induced Constipation Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Opioid-Induced Constipation Market Size by Type
- 9.3.1 APAC (excl. China) Opioid-Induced Constipation Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Opioid-Induced Constipation Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Opioid-Induced Constipation Market Size by Application
- 9.4.1 APAC (excl. China) Opioid-Induced Constipation Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Opioid-Induced Constipation Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Opioid-Induced Constipation Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Opioid-Induced Constipation Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Opioid-Induced Constipation Market Size by Type
- 10.3.1 Latin America Opioid-Induced Constipation Sales by Type (2020-2032)
- 10.3.2 Latin America Opioid-Induced Constipation Revenue by Type (2020-2032)
- 10.4 Latin America Opioid-Induced Constipation Market Size by Application
- 10.4.1 Latin America Opioid-Induced Constipation Sales by Application (2020-2032)
- 10.4.2 Latin America Opioid-Induced Constipation Revenue by Application (2020-2032)
- 10.5 Latin America Opioid-Induced Constipation Market Size by Country
- 10.6 Latin America Opioid-Induced Constipation Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Opioid-Induced Constipation Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Opioid-Induced Constipation Market Size by Type
- 11.3.1 Middle East & Africa Opioid-Induced Constipation Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Opioid-Induced Constipation Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Opioid-Induced Constipation Market Size by Application
- 11.4.1 Middle East & Africa Opioid-Induced Constipation Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Opioid-Induced Constipation Revenue by Application (2020-2032)
- 11.5 Middle East Opioid-Induced Constipation Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Opioid-Induced Constipation Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Opioid-Induced Constipation Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Opioid-Induced Constipation Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Opioid-Induced Constipation Average Sales Price by Manufacturers (2021-2025)
- 12.2 Opioid-Induced Constipation Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Opioid-Induced Constipation Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Ironwood Pharmaceuticals
- 13.1.1 Ironwood Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Ironwood Pharmaceuticals Opioid-Induced Constipation Product Portfolio
- 13.1.3 Ironwood Pharmaceuticals Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Daiichi Sankyo
- 13.2.1 Daiichi Sankyo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Daiichi Sankyo Opioid-Induced Constipation Product Portfolio
- 13.2.3 Daiichi Sankyo Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Pfizer
- 13.3.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Pfizer Opioid-Induced Constipation Product Portfolio
- 13.3.3 Pfizer Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Progenics Pharmaceuticals
- 13.4.1 Progenics Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Progenics Pharmaceuticals Opioid-Induced Constipation Product Portfolio
- 13.4.3 Progenics Pharmaceuticals Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Shionogi
- 13.5.1 Shionogi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Shionogi Opioid-Induced Constipation Product Portfolio
- 13.5.3 Shionogi Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 Allergan
- 13.6.1 Allergan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Allergan Opioid-Induced Constipation Product Portfolio
- 13.6.3 Allergan Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 Nektar Therapeutics
- 13.7.1 Nektar Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Nektar Therapeutics Opioid-Induced Constipation Product Portfolio
- 13.7.3 Nektar Therapeutics Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 Purdue Pharma
- 13.8.1 Purdue Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Purdue Pharma Opioid-Induced Constipation Product Portfolio
- 13.8.3 Purdue Pharma Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 S.L.A. Pharma
- 13.9.1 S.L.A. Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 S.L.A. Pharma Opioid-Induced Constipation Product Portfolio
- 13.9.3 S.L.A. Pharma Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 Mundipharma International
- 13.10.1 Mundipharma International Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Mundipharma International Opioid-Induced Constipation Product Portfolio
- 13.10.3 Mundipharma International Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.11 Ono Pharmaceutical
- 13.11.1 Ono Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Ono Pharmaceutical Opioid-Induced Constipation Product Portfolio
- 13.11.3 Ono Pharmaceutical Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.12 Takeda Pharmaceutical Company
- 13.12.1 Takeda Pharmaceutical Company Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Takeda Pharmaceutical Company Opioid-Induced Constipation Product Portfolio
- 13.12.3 Takeda Pharmaceutical Company Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.13 Theravance Biopharma
- 13.13.1 Theravance Biopharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Theravance Biopharma Opioid-Induced Constipation Product Portfolio
- 13.13.3 Theravance Biopharma Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.14 Bausch Health
- 13.14.1 Bausch Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Bausch Health Opioid-Induced Constipation Product Portfolio
- 13.14.3 Bausch Health Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.15 Cosmo Pharmaceuticals
- 13.15.1 Cosmo Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Cosmo Pharmaceuticals Opioid-Induced Constipation Product Portfolio
- 13.15.3 Cosmo Pharmaceuticals Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.16 Daewoong Pharmaceutical
- 13.16.1 Daewoong Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 Daewoong Pharmaceutical Opioid-Induced Constipation Product Portfolio
- 13.16.3 Daewoong Pharmaceutical Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.17 C.B. Fleet Company
- 13.17.1 C.B. Fleet Company Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 C.B. Fleet Company Opioid-Induced Constipation Product Portfolio
- 13.17.3 C.B. Fleet Company Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.18 Sucampo Pharmaceuticals
- 13.18.1 Sucampo Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.18.2 Sucampo Pharmaceuticals Opioid-Induced Constipation Product Portfolio
- 13.18.3 Sucampo Pharmaceuticals Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Opioid-Induced Constipation Industry Chain Analysis
- 14.2 Opioid-Induced Constipation Industry Raw Material and Suppliers Analysis
- 14.2.1 Opioid-Induced Constipation Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Opioid-Induced Constipation Typical Downstream Customers
- 14.4 Opioid-Induced Constipation Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
